<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032025000200132</article-id>
<article-id pub-id-type="doi">10.35366/119475</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[30 años de experiencia en trasplante de células hematopoyéticas en el Centro de Hematología y Medicina Interna de la Clínica Ruiz de Puebla]]></article-title>
<article-title xml:lang="en"><![CDATA[30 years of experience in hematopoietic stem cell transplantation at Centro de Hematología y Medicina Interna of the Clínica Ruiz in Puebla]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Robles-Nasta]]></surname>
<given-names><![CDATA[Max]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lira-Lara]]></surname>
<given-names><![CDATA[Olivia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olivares-Gazca]]></surname>
<given-names><![CDATA[Juan Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A4"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz-Delgado]]></surname>
<given-names><![CDATA[Guillermo José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ruiz-Argüelles]]></surname>
<given-names><![CDATA[Guillermo José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro de Hematología y Medicina Interna Clínica Ruiz ]]></institution>
<addr-line><![CDATA[Puebla ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Popular Autónoma del Estado de Puebla  ]]></institution>
<addr-line><![CDATA[Puebla ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Veracruzana  ]]></institution>
<addr-line><![CDATA[Veracruz ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de las Américas Puebla  ]]></institution>
<addr-line><![CDATA[Puebla ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2025</year>
</pub-date>
<volume>23</volume>
<numero>2</numero>
<fpage>132</fpage>
<lpage>137</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032025000200132&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032025000200132&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032025000200132&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  el 05 mayo de 1993 se inició el programa de trasplantes de células hematopoyéticas (TCH) en el Centro de Hematología y Medicina Interna de la Clínica Ruiz de Puebla. Hasta la fecha se han realizado 2,095 trasplantes de células hematopoyéticas autólogas y alogénicas, empleando modificaciones de los métodos habituales para llevar a cabo los TCH.  Objetivo:  analizar la experiencia de un solo centro privado a lo largo de 30 años en trasplante de células hematopoyéticas.  Material y métodos:  se analizaron retrospectivamente los expedientes de los pacientes en quienes se hicieron trasplantes de células hematopoyéticas entre los años de 1993 y 2024 en la Clínica Ruiz de Puebla.  Resultados:  en el periodo indicado, se realizaron 2,095 trasplantes, 1,833 TCH autólogas en las siguientes enfermedades: esclerosis múltiple (79.9%), mieloma múltiple (3.7%), leucemia aguda (1.6%), leucemia crónica (0.3%) y linfoma (1.3%). Se hicieron también 262 TCH alogénicas en las siguientes enfermedades: leucemia aguda (6.9%), leucemia crónica (0.7%), hipoplasia medular (0.7%), linfoma (1.3%), mieloma múltiple (0.4%), anemia de Diamond-Blackflan (0.04%), neoplasias no hematológicas (0.3%), mielofibrosis primaria (0.2%), síndromes mielodisplásicos (0.2%), talasemias (0.1%), hemoglobinuria paroxística nocturna (HPN) (0.1%) y síndrome de Hunter (0.04%).  Conclusiones:  con más de 30 años de experiencia hemos podido confirmar que el trasplante de células hematopoyéticas alogénicas y autólogas es el tratamiento de elección para algunas enfermedades autoinmunes y diversas enfermedades oncohematológicas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  on May 5, 1993, the hematopoietic stem cell transplantation (HSCT) program was started at the Centro de Hematología y Medicina Interna de Puebla in the Clínica Ruiz. As of June 2024, 2,095 HSCT have been conducted.  Objective:  to analyze the salient features of the HSCT conducted in a private single center in 30 years.  Material and methods:  the main characteristics of diagnosing persons led to HSCT conducted in the Centro de Hematología y Medicina Interna de Puebla, within the Clínica Ruiz, between 1993 and 2024 were analyzed.  Results:  2,095 transplants were done: 1,833 autologous HSCT and 262 allogeneic HSCT. Autologous grafts were done in: multiple sclerosis (79.9%), multiple myeloma (3.7%), acute leukemia (1.6%), chronic leukemia (0.3%) and lymphoma (1.3%). Whereas allogeneic HSCT was conducted in: acute leukemia (6.9%), chronic leukemia (0.7%), bone marrow hypoplasia (0.7%), lymphoma (1.3%), multiple myeloma (0.4%), Diamond-Blackflan anemia (0.04%), non-hematologic neoplasms (0.3%), primary myelofibrosis (0.2%), myelodysplastic syndrome (0.2%), thalassemias (0.1%), PNH (0.1%), and Hunter syndrome (0.04%).  Conclusions:  with more than 30 years of experience, we have confirmed that both allogeneic and autologous HSCT may be the treatment of choice for some autoimmune diseases and various hematological diseases.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[trasplante]]></kwd>
<kwd lng="es"><![CDATA[autólogo]]></kwd>
<kwd lng="es"><![CDATA[alogénico]]></kwd>
<kwd lng="en"><![CDATA[transplantation]]></kwd>
<kwd lng="en"><![CDATA[autologous]]></kwd>
<kwd lng="en"><![CDATA[allogeneic]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Argüelles]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lessons learned starting a bone marrow transplantation programme in a resource-constrained setting]]></article-title>
<source><![CDATA[Lancet Haematol]]></source>
<year>2020</year>
<volume>7</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>e509-10</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[León-González]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Núñez-Cortés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[León-Peña]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Priego]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zulbarán-Y-Rojas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Delgado]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El programa de trasplantes de células hematopoyéticas de la Clínica Ruiz de Puebla (1993-2016)]]></article-title>
<source><![CDATA[Rev Hematol Mex]]></source>
<year>2016</year>
<volume>17</volume>
<page-range>205-13</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zamora-Ortiz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Velázquez-Sánchez-De-Cima]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez-Reyes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas-Espinosa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Delgado]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Argüelles]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Veinte años de experiencia con trasplantes de células hematopoyéticas en la Clínica Ruiz de Puebla, México]]></article-title>
<source><![CDATA[Rev Hematol Mex]]></source>
<year>2013</year>
<volume>14</volume>
<page-range>63-70</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Delgado]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Arizpe]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Macías-Gallardo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Montes-Montiel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zamora-Ortiz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Argüelles]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El programa de trasplantes de células hematopoyéticas de la Clínica Ruiz de Puebla (1993-2009)]]></article-title>
<source><![CDATA[Rev Hematol Mex]]></source>
<year>2010</year>
<volume>11</volume>
<page-range>15-20</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez-Almaguer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-De León]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Colunga-Pedraza]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Cantú-Rodríguez]]></surname>
<given-names><![CDATA[OG]]></given-names>
</name>
<name>
<surname><![CDATA[Gutierrez-Aguirre]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Ruíz-Arguelles]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outpatient allogeneic hematopoietic stem-cell transplantation: a review]]></article-title>
<source><![CDATA[Ther Adv Hematol]]></source>
<year>2022</year>
<volume>13</volume>
<page-range>20406207221080739</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivera-Franco]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Leon-Rodriguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Castro-Saldaña]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Costs of hematopoietic stem cell transplantation in a developing country]]></article-title>
<source><![CDATA[Int J Hematol]]></source>
<year>2017</year>
<volume>106</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>573-80</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gillis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dann]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rund]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia]]></article-title>
<source><![CDATA[Am J Hematol]]></source>
<year>1996</year>
<volume>51</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-31</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cantú-Rodríguez]]></surname>
<given-names><![CDATA[OG]]></given-names>
</name>
<name>
<surname><![CDATA[Jaime-Pérez]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez-Aguirre]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[González-Llano]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Mancías-Guerra]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tarín-Arzaga]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outpatient allografting using non-myeloablative conditioning: the Mexican experience]]></article-title>
<source><![CDATA[Bone Marrow Transplant]]></source>
<year>2007</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>119-23</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murrieta-Álvarez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Cantero-Fortiz]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[León-Peña]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Olivares-Gazca]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Priesca-Marín]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Delgado]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 1,000th Transplant for multiple sclerosis and other autoimmune disorders at the HSCT-México program: a myriad of experiences and knowledge]]></article-title>
<source><![CDATA[Front Neurol]]></source>
<year>2021</year>
<volume>12</volume>
<page-range>647425</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gratwohl]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Baldomero]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Aljurf]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pasquini]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Bouzas]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshimi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hematopoietic stem cell transplantation: a global perspective]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2010</year>
<volume>303</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1617-24</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharrack]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Saccardi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Badoglio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Burman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Farge]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)]]></article-title>
<source><![CDATA[Bone Marrow Transplant]]></source>
<year>2020</year>
<volume>55</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>283-306</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohammadi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aryan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Omrani]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Ghaderian]]></surname>
<given-names><![CDATA[SMH]]></given-names>
</name>
<name>
<surname><![CDATA[Fazeli]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autologous hematopoietic stem cell transplantation (AHSCT): an evolving treatment avenue in multiple sclerosis]]></article-title>
<source><![CDATA[Biologics]]></source>
<year>2021</year>
<volume>15</volume>
<page-range>53-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Anazi]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autologous hematopoietic stem cell transplantation for multiple myeloma without cryopreservation]]></article-title>
<source><![CDATA[Bone Marrow Res]]></source>
<year>2012</year>
<volume>2012</volume>
<page-range>917361</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naithani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dayal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Pathak]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rai]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hematopoietic stem cell transplantation using non-cryopreserved peripheral blood stem cells graft is effective in multiple myeloma and lymphoma]]></article-title>
<source><![CDATA[Bone Marrow Transplant]]></source>
<year>2018</year>
<volume>53</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1198-200</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Fenk]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Saure]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Czibere]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bruns]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Zohren]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Mexican way: a feasible approach to avoid DMSO toxicity]]></article-title>
<source><![CDATA[Bone Marrow Transplant]]></source>
<year>2011</year>
<volume>46</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>469-71</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarmiento]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Parody]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Salas]]></surname>
<given-names><![CDATA[MQ]]></given-names>
</name>
<name>
<surname><![CDATA[Beffermann]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Jara]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy]]></article-title>
<source><![CDATA[Bone Marrow Transplant]]></source>
<year>2018</year>
<volume>53</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>960-6</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Blazar]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antibody based conditioning for allogeneic hematopoietic stem cell transplantation]]></article-title>
<source><![CDATA[Front Immunol]]></source>
<year>2022</year>
<volume>13</volume>
<page-range>1031334</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
